VCP
ZBH icon

Verus Capital Partners’s Zimmer Biomet ZBH Stock Holding History

Verus Capital Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$80K Buy
815
+258
+46% +$33.8K 0.03% 361
2019
Q4 		$81K Buy
+557
New +$76.9K 0.03% 445

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Verus Capital Partners's ZBH Position: Q1 2020 in Review

Verus Capital Partners increased its Zimmer Biomet (ZBH) stake by 46% in Q1 2020, buying an estimated $33.8K and bringing the position to 815 shares worth $80K. The position accounts for 0.03% of the portfolio, ranked #361.

Verus Capital Partners first reported a position in ZBH in Q4 2019 and has held it in 2 quarters since. The position peaked at $81K in Q4 2019. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

  • Verus Capital Partners held 815 shares of Zimmer Biomet worth $80K as of Q1 2020.
  • Verus Capital Partners bought 258 Zimmer Biomet shares in Q1 2020, an estimated $33.8K.
  • Zimmer Biomet made up 0.03% of Verus Capital Partners's portfolio in Q1 2020, its #361 holding.
  • Verus Capital Partners first reported a position in Zimmer Biomet in Q4 2019 and has held it in 2 quarters since.
  • Verus Capital Partners's Zimmer Biomet position peaked at $81K in Q4 2019.
  • 883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.